Section Arrow
VERA.NASDAQ
- Vera Therapeutics
Quotes are at least 15-min delayed:2026/01/09 02:58 EST
Regular Hours
Last
 47.69
-0.99 (-2.03%)
Day High 
48.69 
Prev. Close
48.68 
1-M High
56.05 
Volume 
1.05M 
Bid
46
Ask
48.6
Day Low
47.28 
Open
48.44 
1-M Low
40.38 
Market Cap 
3.46B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 50.81 
20-SMA 49.58 
50-SMA 38.43 
52-W High 56.05 
52-W Low 18.53 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.99/0.84
Enterprise Value
3.51B
Balance Sheet
Book Value Per Share
5.62
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1033-0.0223-17.75%-- 
ACRVAcrivon Therapeutics1.93-1.02-34.58%-- 
VTYXVentyx Biosciences13.84+0.11+0.80%-- 
MLTXMoonLake Immunotherapeutics14.34+3.05+27.02%-- 
CRMDCorMedix7.51-3.66-32.77%5.05PE
Industry overview quotes are at least 15 minutes delayed
Business Description
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.